Escolar Documentos
Profissional Documentos
Cultura Documentos
Objective: Evaluate the basic proficiency in utilizing an alternate source of drug information.
Name of the Drug: LIDOCAINE
IUPAC NAME
DESCRIPTION
2-(diethylamino)-N-(2,6dimethylphenyl)acetamide
SOURCES
https://pubchem.ncbi.nlm.nih.g
ov/compound/lidocaine#section
=Names-and-Identifiers
https://pubchem.ncbi.nlm.nih.g
ov/compound/lidocaine#section
=Names-and-Identifiers
Trade name
Lignopad
Manufacturer
Mundipharma
Xylocaine
AstraZeneca
Enducaine
Accucaine
Asthesia
Unichem
https://www.mims.com/philippines
/drug/info/lidocaine/?
type=brief&mtype=generic
https://www.mims.com/philippines
/drug/info/lidocaine/?
type=brief&mtype=generic
http://www.fda.gov.ph/consumerscorner/registered-drugs-2/192018dr-xy30205-192018
http://www.drugbank.ca/drugs/DB
00281
http://www.mims.com/india/drug/i
nfo/asthesia/asthesia
%20cream#Manufacturer
CHEMICAL
STRUCTURE
TRADE
NAMES AND
PRICES
VARIOUS
DOSAGE
FORMS AND
STRENGTHS
ADULT
Infiltration Anesthesia
Percutaneous: 1-60 mL of 0.5-1% solution (5-300 mg total
dose)
IV regional: 10-60 mL of 0.5% solution (50-300 mg total dose)
Dosing Considerations
Use preservative-free preparations for spinal or epidural
anesthesia
May be buffered 9:1 with sodium bicarbonate, to reduce pain on
injection (e.g. remove 2 mL of 1% lidocaine from 20 mL vial, and
add 2 mL of sodium bicarbonate solution to vial)
Maximum dose: 4.5 mg/kg, up to 300 mg lidocaine without
epinephrine; or 7 mg/kg, up to 500 mg lidocaine with
epinephrine
PEDIATRIC
Infiltration
http://reference.medscape.com/
drug/xylocaine-zingo-lidocaineanesthetic-343363
CLINICAL
INDICATIONS
PREGNANCY
CATEGORY
http://www.drugbank.ca/drugs/
DB00281
http://www.mims.com/india/dr
ug/info/lidocaine/?
type=brief&mtype=generic